Quoted Micro 5 January 2026

AQUIS STOCK EXCHANGE Energy efficient technology developer Time to ACT (TTA) was held back by volatility of orders. In the six months to September 2025, revenues fell from £1.67m to £732,000, while the loss increased from £184,000 to £698,000. There are more than £4m of Large Parts contacts ready to be closed. In November 2025, […]

Quoted Micro 20 October 2025

AQUIS STOCK EXCHANGE ProBiotix Health (PBX) increased sales 30% to £1.97m in the nine months to September 2025. There is sufficient cash for the company’s needs. A commercial partnership with RevivaBio has been set up to launch a new cholesterol lowering product powered by the ProBiotix patented probiotic strain LPLDL®. Chairman Adam Rynolds bought 100,000 […]

Quoted Micro 15 September 2025

AQUIS STOCK EXCHANGE Newbury Racecourse (NYR) increased interim turnover 4% to £9.67m and the loss reduced to £150,000. Hospitality, hotel and nursery revenues all increased. Higher attendances improved core revenues as well. Changes in betting tax rates could hold back racing revenues. ProBiotix Health (PBX) increased interim revenues by one-third to £1.34m. This helped to […]

Quoted Micro 1 September 2025

AQUIS STOCK EXCHANGE HRC World (HRC) joined Aquis on 26 August. The data centre facilities provider is already traded on Nasdaq First Copenhagen. The plan is to expand the network of sites outside of Malaysia. It is also assessing sustainable electricity generation potential.         The Smarter Web Company (SWC) has raised a further £3.66m at […]